drugset / Trial / NCT01786915
Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose of this study is to assess the study medication blood levels after administration of a repeat oral capsules (one capsule each day for seven days) of Bendavia at one of two dose levels. The effects of Bendavia on the volunteers will also be assessed.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elamipretide | Peptide | 10 mg | Oral |
| Subject | Elamipretide | Peptide | 50 mg | Oral |
Indications
No indication recorded.